We have a positive impact on the world by growing innovative businesses
Australian Companies
Flexible Support, Maximum Impact
Part time retainer services to fill existing gaps in your team, without the commitment of hiring permanent staff.
Technical Support
Technical expertise supporting manufacturing processes and project development and management including regulatory guidance.
Strategy Support
Leverage our extensive commercialisation experience, working in industry, government programs and research organisations.
Global Companies
Market Research
Helping you to navigate the Australian Life Sciences ecosystem and understanding current trends and drivers for the MedTech and Pharma industry.
Stakeholder Engagement
Leverage our deep networks in the Australian industry and research sector to connect with valuable partners and build long term strategic connections.
Market Strategy
Develop effective plans for optimal Australian market entry including navigating barriers to entry and development of a proactive engagement strategy.
Trust
We believe in doing the right thing because it is the right thing to do.
Connection
Our interactions are built on authentic human connections.
Value
We remain committed to recognising and preserving true value, which goes beyond monetary measures.
Impact
We are driven to creating meaningful and positive contributions for our clients and society.
We are inspired by beautiful places in the natural world, which keep alive our passion and focus on what matters most.
PhD | MBA | GAICD
Biotech and Pharma
MedTech
Governance
Business Strategy
Deep Tech Commercialisation
Kerstin is an experienced Executive and Non-Executive Director with a uniquely developed skill set and proven record in technology commercialisation, stakeholder engagement and partnering with industries and universities at an international level. Well - practiced in research, global and start-up businesses as well as government funding programs, she has deep expertise in the Biotech, Pharma and AgTech sector. Kerstin is a strong connector and passionate about the commercialisation of new technologies that benefit society. With an entrepreneurial spirit, she has mentored multiple start-ups through Strandnberg, incubators and government grant programs such as Accelerating Commercialisation. Her industry experience includes working globally with Pfizer and global CDMO Vetter Pharma, as well as senior roles in Biotech which included establishing the drug discovery group at Bionomics, which has led to a phase II asset. Her focus is on enabling strategic global and national collaborations and connections, which are critical in the translation of Intellectual Property. She believes in paying it forward by sharing knowledge and networks.
Kerstin's experience includes board and advisory positions. She is currently a member of Walter Eliza Hall’s 66ten Investment Review Committee and participates in investment review panels for the South Australian government. Kerstin has recently also joined the federal governments flagship Industry Growth Program as a facilitator, directly impacting on the growth of the Australian innovation ecosystem. Few things are as rewarding as contributing to products reaching global market, having a direct positive impact on society and the economy.
PhD
Biotech and Pharma
Formulation and Process Development
Manufacturing
IP Strategy
Regulatory Strategy
With a PhD in Organic Chemistry, plus 17+ years’ experience at Pfizer in the design, development and submission of pharmaceutical drugs, Andrew can provide expert advice on what is required to get drugs to market.
During his time in the pharmaceutical industry, he has worked on formulation, process and method development, extractable and leachable testing, impurity isolation and identification and dossier writing and submission for national and international regulatory agencies.
He has had several face-to-face meetings with the FDA, EMEA, TGA and PMDA and is an author of formulation and manufacturing process patents which are currently being used for product protection at Pfizer. Andrew has been a subject matter expert responsible for the innovative research at several international patent infringement cases.
PhD
Biotech and Pharma
MedTech
Governance
Business Strategy
Deep Tech Commercialisation
Kylie is an experienced business strategist with a background in biotech leadership, business partnering and technology commercialisation. She leverages her scientific expertise to develop custom solutions for clients with a technical and commercial lens. Her consultation expertise encompasses business strategy, operational improvements, market assessment and go-to-market strategy development. Kylie is dedicated to advancing biotechnology and making a positive impact on the industry and its patients.
Strandnberg was founded with a genuine purpose to create positive impact by helping new medical technologies to reach the market globally. We believe in the importance of global connections, technical excellence and effective strategy development to help our clients achieve their goals.
We work with clients nationally and globally. We have office locations in Adelaide, Melbourne and Brisbane.
Please direct all initial enquiries to:
Dr Kerstin Schütz
Phone: 0431360810
Email: kerstin@strandnberg.com